We are live on ! Find out more
AXLA

Axcella Health Inc. Common Stock

Delisted

AXLA was delisted on the 22nd of November, 2023.

34 hedge funds and large institutions have $15.9M invested in Axcella Health Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 4

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

6% more funds holding

Funds holding: 3234 (+2)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

73% less capital invested

Capital invested by funds: $58.3M → $15.9M (-$42.5M)

Holders
34
Holders Change
+2
Holders Change %
+6.25%
% of All Funds
0.55%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
8
Increased
12
Reduced
4
Closed
6
Calls
$1K
Puts
Net Calls
+$1K
Net Calls Change
+$1K

AXLA Hedge Fund Activity: Q4 2022 in Review

34 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q4 2022, worth a combined $15.9M — down 73% from $58.3M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new AXLA positions and 6 closed out — a net gain of 2 holders — while 12 added to existing stakes and 4 trimmed.

The largest buyer was Flagship Pioneering, adding an estimated $10.8M. The largest seller was Artal Group, exiting entirely with an estimated $1.22M sold.

  • 34 institutional investors held Axcella Health Inc. Common Stock (AXLA) as of Q4 2022, up from 32 in Q3 2022.
  • Funds reported $15.9M of Axcella Health Inc. Common Stock stock for Q4 2022, down 73% quarter-over-quarter.
  • 8 funds opened new Axcella Health Inc. Common Stock positions in Q4 2022 and 6 closed out, a net change of +2 holders.
  • The largest Axcella Health Inc. Common Stock buyer in Q4 2022 was Flagship Pioneering, an estimated $10.8M added.
  • The largest Axcella Health Inc. Common Stock seller in Q4 2022 was Artal Group, an estimated $1.22M sold.

Based on aggregated 13F filings for Q4 2022.